Two Sigma Securities’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-52,320
| Closed | -$61.2K | – | 2109 |
|
|
2024
Q2 | $61.2K | Sell |
52,320
-32,993
| -39% | -$38.6K | ﹤0.01% | 1119 |
|
|
2024
Q1 | $107K | Buy |
85,313
+40,839
| +92% | +$51.5K | ﹤0.01% | 988 |
|
|
2023
Q4 | $79.2K | Buy |
+44,474
| New | +$79.2K | ﹤0.01% | 985 |
|
|
2023
Q3 | – | Sell |
-15,276
| Closed | -$30.6K | – | 1850 |
|
|
2023
Q2 | $30.6K | Sell |
15,276
-5,484
| -26% | -$11K | ﹤0.01% | 942 |
|
|
2023
Q1 | $43.6K | Buy |
+20,760
| New | +$43.6K | ﹤0.01% | 994 |
|
|
2018
Q1 | – | Sell |
-5,713
| Closed | -$38K | – | 1490 |
|
|
2017
Q4 | $38K | Buy |
5,713
+950
| +20% | +$6.32K | ﹤0.01% | 865 |
|
|
2017
Q3 | $28K | Buy |
+4,763
| New | +$28K | ﹤0.01% | 750 |
|
|
2015
Q2 | – | Sell |
-1,115
| Closed | -$20K | – | 244 |
|
|
2015
Q1 | $20K | Buy |
+1,115
| New | +$20K | 0.02% | 177 |
|